Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate
Author(s) -
Kathryn Lurain,
Thomas S. Uldrick,
Ramya Ramaswami,
Mark N. Polizzotto,
Priscila Gonçalves,
Anaida Widell,
Seth M. Steinberg,
Elaine S. Jaffe,
Stefania Pittaluga,
HaoWei Wang,
Constance M. Yuan,
Mary Anne Tamula,
Staci Martin,
Pamela L. Wolters,
Jomy George,
Richard F. Little,
Robert Yarchoan
Publication year - 2020
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2020006048
Subject(s) - rituximab , medicine , primary central nervous system lymphoma , methotrexate , lymphoma , antiretroviral therapy , immunology , human immunodeficiency virus (hiv) , oncology , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom